Recombinant erythropoietin

payment options for Medicare.

By United States. Congress. Office of Technology Assessment

0 (0 Ratings)

0 Want to read0 Currently reading0 Have read

Publish Date

1990

Publisher

Congress of the U.S., Office of Technology Assessment,For sale by the Supt. of Docs., U.S. G.P.O.

Language

eng

Pages

101

Description:

subjects: Renal anemia, Treatment, Technological innovations, Recombinant erythropoietin, Therapeutic use, Economic aspects, Medicare, Anemia, Drug therapy, Erythropoietin, Recombinant Proteins, Economics

Places: United States